PROX1 is a predictor of survival for gliomas WHO grade II

BACKGROUND: The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers that can predict prognosis in individual patients is of great clinical value. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsir, T, Qu, M, Berntsson, S G, Orrego, A, Olofsson, T, Lindström, M S, Nistér, M, von Deimling, A, Hartmann, C, Ribom, D, Smits, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111172/
https://www.ncbi.nlm.nih.gov/pubmed/21559010
http://dx.doi.org/10.1038/bjc.2011.162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111172/
https://www.ncbi.nlm.nih.gov/pubmed/21559010
http://dx.doi.org/10.1038/bjc.2011.162

Ejemplares similares